WW · WW International Inc.
AI read · Bad for WW
The AI's read
WW is counting on growth in its clinical service to help make up for losses in its larger behavioral service. Growth in Core+ and clinical subscriptions is encouraging, but total subscribers fell, and clinical subscribers also slipped from June. WW also returned to profit, and its adjusted EBITDA rose. But marketing spending had been cut, and the company plans to raise it again in the fourth quarter. Its 2027 recovery plan is a goal, not a result.